HANSEN GWENN (Chief Scientific Officer) sold 2.6% of their position (3.21K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $53.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+2K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.75K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.86K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−3.21K
Price / share
$16.65
Trade value
$53.50K
% of position
Net shares
+5.39K
Net value
-$53.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2026 | M · Option Exercise | +2K | — | — | 1.7% | 115K | 117K |
| Common Stock Direct | 4/30/2026 | M · Option Exercise | +3.75K | — | — | 3.2% | 117K | 120.75K |
| Common Stock Direct | 4/30/2026 | M · Option Exercise | +2.86K | — | — | 2.4% | 120.75K | 123.61K |
| Common Stock Direct | 4/30/2026 | S · Sale | −3.21K | $16.65 | $53.50K | 2.6% | 123.61K | 120.40K |
| Total | +5.39K | -$53.50K | ||||||
Restricted Stock Units
Common Stock
2K shares
Shares
−2K
Strike price
0
Held after
0.00
Exercisable
—
Restricted Stock Units
Common Stock
3.75K shares
Shares
−3.75K
Strike price
0
Held after
15K
Exercisable
—
Restricted Stock Units
Common Stock
2.86K shares
Shares
−2.86K
Strike price
0
Held after
22.87K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2K shares | 4/30/2026 | M · Option Exercise | −2K | 0 | — | 0.00 |
| Restricted Stock Units Direct | Common Stock3.75K shares | 4/30/2026 | M · Option Exercise | −3.75K | 0 | — | 15K |
| Restricted Stock Units Direct | Common Stock2.86K shares | 4/30/2026 | M · Option Exercise | −2.86K | 0 | — | 22.87K |